4.7 Review

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis

Journal

LANCET NEUROLOGY
Volume 9, Issue 9, Pages 921-932

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(10)70168-X

Keywords

-

Funding

  1. Novartis
  2. Biogen Idec
  3. Bayer Schering Pharma
  4. Merck Serono
  5. Sanofi-Aventis
  6. Teva
  7. Vertex
  8. Bayer
  9. Genentech
  10. Serono
  11. Novo Nordisk
  12. Centacor
  13. Bayer Schering
  14. GlaxoSmithKline
  15. UCB
  16. Actelion
  17. Roche
  18. Antisense Therapeutics
  19. Foundation for Fundamental Research on Matter
  20. Netherlands Organisation for Scientific Research
  21. US National Institutes of Health
  22. National Eye Institute of the National Institutes of Health
  23. National Institutes of Health
  24. Howard Hughes Medical Institute
  25. National MS Society
  26. American Academy of Neurology Foundation

Ask authors/readers for more resources

Optical coherence tomography (OCT) is a new method that could aid analysis of neurodegeneration in multiple sclerosis (MS) by capturing thinning of the retinal nerve fibre layer (RNFL). Meta-analyses of data for time domain OCT show RNFL thinning of 20.38 pm (95% CI 17-91-22.86, n=2063, p<0.0001) after optic neuritis in MS, and of 7.08 mu m (5.52-8.65, n=3154, p<0.0001) in MS without optic neuritis. The estimated RNFL thinning in patients with MS is greater than the extent expected in normal ageing, probably because of retrograde trans-synaptic degeneration and progressive loss of retinal ganglion cells, in addition to the more pronounced thinning caused by optic neuritis if present. RNFL thickness correlates with visual and neurological functioning as well as with paradinical data. Developments that could improve understanding of the relation between structure and function in MS pathophysiology include spectral or Fourier domain OCT technology, polarisation-sensitive OCT, fluorescence labelling, structural assessment of action-potential propagation, and segmentation algorithms allowing quantitative assessment of retinal layers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available